A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring

NAEnrolling by invitationINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

March 31, 2028

Conditions
Type 2 Diabetes
Interventions
BEHAVIORAL

Pharmacist Only

Clinical pharmacists conduct encounters with patients by videoconferencing or phone. Pharmacists conduct a broad range of activities including ongoing evaluation of medication and lifestyle adherence, setting therapeutic goals, formulating a provider-approved plan of care, and documenting the plan in the electronic health record. Pharmacists propose medication changes based on algorithms and protocols derived from national guidelines under physician guidance.

DEVICE

Continuous Glucose Monitor (CGM)

Patients will receive the Continuous Glucose Monitoring (CGM) system. The instruction on use of device is the intervention being tested, not the effectiveness of the device itself. Participants will receive instruction and training on how to use the device and will wear the device for 10 days.

BEHAVIORAL

Community Health Worker (CHW)

Patients are connected to a community health worker(CHW). CHWs conduct home visits and facilitate 3-way Telehealth visits (Patients, pharmacists, and CHWs) via an iPad with cellular plan. Additional CHW activities include social determinants of health screening, health behavior education, problem solving, goal setting, and medication adherence support.

Trial Locations (1)

01605

University of Massachusetts, Worcester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Baystate Health

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Massachusetts, Worcester

OTHER